Danaher/$DHR
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Danaher
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Ticker
$DHR
Sector
Primary listing
NYSE
Employees
62,000
Headquarters
Website
Danaher Metrics
BasicAdvanced
$142B
42.15
$4.71
0.80
$1.18
0.64%
Price and volume
Market cap
$142B
Beta
0.8
52-week high
$275.50
52-week low
$171.00
Average daily volume
3.5M
Dividend rate
$1.18
Financial strength
Current ratio
1.619
Quick ratio
1.1
Long term debt to equity
34.49
Total debt to equity
35.45
Dividend payout ratio (TTM)
23.85%
Interest coverage (TTM)
17.64%
Profitability
EBITDA (TTM)
7,521
Gross margin (TTM)
59.82%
Net profit margin (TTM)
14.21%
Operating margin (TTM)
21.38%
Effective tax rate (TTM)
16.27%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
4.03%
Return on equity (TTM)
6.68%
Valuation
Price to earnings (TTM)
42.151
Price to revenue (TTM)
5.953
Price to book
2.72
Price to tangible book (TTM)
-15.31
Price to free cash flow (TTM)
29.4
Free cash flow yield (TTM)
3.40%
Free cash flow per share (TTM)
6.756
Dividend yield (TTM)
0.59%
Forward dividend yield
0.64%
Growth
Revenue change (TTM)
1.89%
Earnings per share change (TTM)
-16.41%
3-year revenue growth (CAGR)
-7.98%
10-year revenue growth (CAGR)
3.80%
3-year earnings per share growth (CAGR)
-17.83%
10-year earnings per share growth (CAGR)
2.63%
3-year dividend per share growth (CAGR)
8.65%
10-year dividend per share growth (CAGR)
9.64%
What the Analysts think about Danaher
Analyst ratings (Buy, Hold, Sell) for Danaher stock.
Bulls say / Bears say
Danaher's Bioprocessing segment delivered 6% core revenue growth in Q2 2025 and expanded its adjusted operating profit margin by 150 basis points to 41.0%, underscoring strong demand for consumables. (Investing.com)
Management raised full-year 2025 adjusted diluted EPS guidance to $7.70–$7.80 from $7.60–$7.75, reflecting confidence in operational execution and earnings momentum. (Investing.com)
The operating cash flow to net earnings conversion ratio improved to 2.41x and the free cash flow conversion ratio rose to 1.97x in Q2, highlighting enhanced cash generation efficiency. (Investing.com)
Core revenue in the Life Sciences segment declined 2.5% year-over-year in Q2 2025, resulting in a $239 million operating loss and signaling ongoing headwinds in that business. (Nasdaq)
Q3 2025 revenue guidance implies quarterly sales of $5.94 billion, about 1% below analysts’ consensus of $6.01 billion, suggesting potential near-term revenue shortfall. (Finviz)
Danaher faced a mid-single-digit decline in China in Q2, weighing on overall growth in a key market. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.
Danaher Financial Performance
Revenues and expenses
Danaher Earnings Performance
Company profitability
Danaher News
AllArticlesVideos
EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
Business Wire4 weeks ago
Danaher Stock Closes Near Day's High After Key Trading Signal
Benzinga1 month ago
Investors decided the good outweighs the bad with Danaher, says Jim Cramer
CNBC Television2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Danaher stock?
Danaher (DHR) has a market cap of $142B as of September 09, 2025.
What is the P/E ratio for Danaher stock?
The price to earnings (P/E) ratio for Danaher (DHR) stock is 42.15 as of September 09, 2025.
Does Danaher stock pay dividends?
Yes, the Danaher (DHR) stock pays dividends to shareholders. As of September 09, 2025, the dividend rate is $1.18 and the yield is 0.64%. Danaher has a payout ratio of 23.85% on a trailing twelve-month basis.
When is the next Danaher dividend payment date?
The next Danaher (DHR) dividend payment date is unconfirmed.
What is the beta indicator for Danaher?
Danaher (DHR) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.